Jane Loftus

1.1k total citations
55 papers, 816 citations indexed

About

Jane Loftus is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Jane Loftus has authored 55 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Pediatrics, Perinatology and Child Health and 15 papers in Molecular Biology. Recurrent topics in Jane Loftus's work include Growth Hormone and Insulin-like Growth Factors (26 papers), Childhood Cancer Survivors' Quality of Life (16 papers) and Sexual Differentiation and Disorders (13 papers). Jane Loftus is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (26 papers), Childhood Cancer Survivors' Quality of Life (16 papers) and Sexual Differentiation and Disorders (13 papers). Jane Loftus collaborates with scholars based in United Kingdom, United States and Germany. Jane Loftus's co-authors include Marla B. Sultan, Kathleen Ice, Duo Zhou, Andrew Lotery, Andreas M. Pleil, Martin Jones, David J. Gallacher, George A Fox, S. D. Shackelford and Stephen H. Landy and has published in prestigious journals such as PLoS ONE, Stroke and Ophthalmology.

In The Last Decade

Jane Loftus

50 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Loftus United Kingdom	15	297	224	188	166	121	55	816
J F Talbot United Kingdom	17	581 2.0×	423 1.9×	76 0.4×	103 0.6×	307 2.5×	36	1.2k
E. Hendrich Australia	6	88 0.3×	57 0.3×	179 1.0×	169 1.0×	65 0.5×	8	1.1k
Heike M. Elflein Germany	17	404 1.4×	487 2.2×	91 0.5×	34 0.2×	118 1.0×	47	880
P. S. Sharp United Kingdom	19	127 0.4×	118 0.5×	1.0k 5.5×	263 1.6×	170 1.4×	30	1.7k
Anna‐Lena Hård Sweden	18	190 0.6×	931 4.2×	90 0.5×	78 0.5×	959 7.9×	28	1.6k
Niels Vesti Nielsen Denmark	21	1.1k 3.6×	670 3.0×	60 0.3×	205 1.2×	32 0.3×	59	1.4k
W. A. J. van Heuven United States	13	606 2.0×	566 2.5×	124 0.7×	95 0.6×	126 1.0×	28	987
Vytenis Pranas Deltuva Lithuania	18	36 0.1×	61 0.3×	137 0.7×	159 1.0×	45 0.4×	53	817
Richard P. Mills United States	21	1.2k 3.9×	654 2.9×	57 0.3×	65 0.4×	53 0.4×	62	1.5k
Yinxi Yu United States	16	342 1.2×	325 1.5×	29 0.2×	44 0.3×	168 1.4×	88	816

Countries citing papers authored by Jane Loftus

Since Specialization

Citations

This map shows the geographic impact of Jane Loftus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Loftus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Loftus more than expected).

Fields of papers citing papers by Jane Loftus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Loftus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Loftus. The network helps show where Jane Loftus may publish in the future.

Co-authorship network of co-authors of Jane Loftus

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Loftus. A scholar is included among the top collaborators of Jane Loftus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Loftus. Jane Loftus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alvir, José, et al.. (2025). Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational study. Orphanet Journal of Rare Diseases. 20(1). 90–90.

Loftus, Jane, Bradley S. Miller, Craig S. Parzynski, et al.. (2025). A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication. Therapeutic Advances in Endocrinology and Metabolism. 16. 2455677726–2455677726.

Gomez, Roy, Roger E. Lamoureux, Diane M. Turner‐Bowker, et al.. (2023). Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study. Frontiers in Endocrinology. 14. 1254424–1254424. 6 indexed citations

Loftus, Jane, Bradley S. Miller, Craig S. Parzynski, et al.. (2022). Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency. Endocrine Practice. 28(6). 565–571. 21 indexed citations

Loftus, Jane, et al.. (2022). Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK. Frontiers in Endocrinology. 13. 1014743–1014743. 4 indexed citations

Salvatori, Roberto, Pietro Maffei, Susan M. Webb, et al.. (2022). Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary. 25(3). 420–432. 10 indexed citations

Loftus, Jane, et al.. (2022). Experience of switching from a daily to a less frequent administration of injection treatments. PLoS ONE. 17(11). e0278293–e0278293. 9 indexed citations

Loftus, Jane, et al.. (2020). PDB4 Evaluation of Quality of Life in PRE-Pubertal Children Using the Quality of Life in Short Stature Youth (QOLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment with Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule. Value in Health. 23. S506–S506. 1 indexed citations

Turner‐Bowker, Diane M., Andrew Yaworsky, Andrew Palladino, et al.. (2020). Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults. Patient. 13(3). 289–306. 10 indexed citations

10.

Turner‐Bowker, Diane M., Andrew Yaworsky, Roger E. Lamoureux, et al.. (2019). CL1 DEFINING AND DEMONSTRATING A CHILD-CAREGIVER DYAD QUESTIONNAIRE ADMINISTRATION APPROACH TO THE ASSESSMENT OF PEDIATRIC HEALTH-RELATED QUALITY OF LIFE. Value in Health. 22. S35–S35. 1 indexed citations

11.

Loftus, Jane, Andreas M. Pleil, Roger E. Lamoureux, et al.. (2018). Burden and Impacts of Daily Recombinant Human Growth Hormone (r-hGH) Injections in Growth Hormone Deficient (GHD) Paediatric Patients. 89. 1 indexed citations

12.

McNamara, Michelle, H.J. Gross, Diane M. Turner‐Bowker, et al.. (2018). PDB125 - A DISCRETE CHOICE EXERCISE TO EVALUATE FACTORS DRIVING GROWTH HORMONE DEFICIENT (GHD) PATIENT PREFERENCES FOR INJECTION AND INJECTION DEVICE FEATURES. Value in Health. 21. S139–S140. 2 indexed citations

13.

Stewart, Michelle, et al.. (2018). Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers. Neurology and Therapy. 7(2). 349–364. 52 indexed citations

14.

Loftus, Jane, et al.. (2013). Psychometric validation of the visual function questionnaire-25 in patients with diabetic macular edema. Health and Quality of Life Outcomes. 11(1). 10–10. 26 indexed citations

15.

Kaspers, Stefan, Michael B. Ranke, Jane Loftus, et al.. (2013). Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome. Applied Health Economics and Health Policy. 11(3). 237–249. 14 indexed citations

16.

Ranke, Michael B., Anders Lindberg, Stefan Kaspers, et al.. (2012). Accurate Long-Term Prediction of Height during the First Four Years of Growth Hormone Treatment in Prepubertal Children with Growth Hormone Deficiency or Turner Syndrome. Hormone Research in Paediatrics. 78(1). 8–17. 15 indexed citations

17.

Pleil, Andreas M., Jack Mardekian, & Jane Loftus. (2011). Diabetic Macular Edema (DME) and Treatment of the Better-Seeing Eye - An Experimental Bias for Vision-Related Quality of Life (VRQoL) Outcomes?. Investigative Ophthalmology & Visual Science. 52(14). 577–577. 1 indexed citations

18.

Orme, Michelle, et al.. (2011). Long-term Medical Management of Primary Open-Angle Glaucoma and Ocular Hypertension in the UK. Journal of Glaucoma. 21(7). 433–449. 11 indexed citations

19.

Sultan, Marla B., et al.. (2011). A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema. Ophthalmology. 118(6). 1107–1118. 127 indexed citations

20.

Magrina, J.F., et al.. (2004). Effects of raloxifene hydrochloride on endometrial cancer cells in vitro. Gynecologic Oncology. 93(3). 642–646. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact